drugset / Trial / NCT02469883
A Study of Sinotecean on Tolerance and Pharmacokinetics
NaSingle-groupOpen-labelTreatment
Summary
This study is conducted to assess the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT), to evaluate the pharmacokinetics, safety and preliminary anti-tumor activity of Sinotecean.
Timeline
- Start
- 2015-03
- Primary completion
- 2016-08
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sinotecean | Unknown | — | — |